| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |